Comparative prognostic value of hemoglobin glycation index and glycation gap for mortality risk in adults: A
Xiaoying Sun1, Ping Yu1, Chun Zhang2
1Department of Endocrinology, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, Huzhou, China.
Insights
The hemoglobin glycation index (HGI) and glycation gap (GG) can help predict mortality risk. Combined assessment of HGI and GG aids in identifying individuals at higher risk for cardiovascular disease (CVD) and all-cause mortality.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Epidemiology
Background:
- Hemoglobin A1c (HbA1c) is a standard diabetes marker, but individual glycation levels vary.
- Hemoglobin glycation index (HGI) and glycation gap (GG) quantify this discordance.
- These markers may offer insights beyond HbA1c alone.
Purpose of the Study:
- To compare the predictive capabilities of HGI and GG for all-cause and cardiovascular disease (CVD) mortality.
- To assess the utility of HGI and GG in a nationally representative adult population.
- To evaluate the combined predictive value of HGI and GG.
Main Methods:
- Utilized data from 3468 adults in the US National Health and Nutrition Examination Survey (1999-2004).
- Stratified participants based on median absolute values of HGI and GG.
- Employed Cox proportional hazard models and time-dependent receiver-operating characteristic (ROC) curves to analyze associations with mortality.
Main Results:
- Over a median follow-up of 101 months, 733 (12.48%) deaths occurred, including 210 from CVD.
- The HGI+/GG+ group showed significantly higher hazard ratios for all-cause (1.36) and CVD mortality (1.91) compared to the HGI-/GG- group.
- Both HGI and GG demonstrated comparable predictive accuracy (AUC 0.50-0.60) with a linear relationship to mortality risk.
Conclusions:
- HGI and GG are valuable markers for predicting mortality risk, particularly CVD mortality.
- Combined assessment of HGI and GG enhances risk stratification and identification of high-risk individuals.
- These glycation markers provide additional prognostic information beyond standard HbA1c measurements.
Abstract:
ObjectiveThis study aimed to compare hemoglobin glycation index (HGI) and glycation gap (GG), markers of the discordance between measured and predicted hemoglobin A1c levels, for predicting all-cause and cardiovascular disease (CVD) mortality in a nationally representative population.MethodsData of 3468 adults were retrieved from the 1999-2004 US National Health and Nutrition Examination Survey. Participants were stratified into four groups based on the median of absolute values of HGI and GG. Associations between HGI, GG and mortality risk were evaluated with Cox proportional hazard model and time-dependent receiver-operating characteristic curves.ResultsOver a median follow-up of 101 months, 733 (12.48%) participants died, of which 210 were from CVD causes. Compared to the HGI-/GG-group, the HGI+/GG+ group had an hazard ratio (95% confidence interval) of 1.36 (1.02-1.82) for all-cause mortality and 1.91 (1.00-3.64) for CVD mortality. Restricted cubic spline curves demonstrated a positively linear relationship between absolute values of HGI, GG and mortality risk. Time-dependent receiver-operating characteristic curves revealed comparable predictive accuracy for HGI and GG, with area under the curve ranged between 0.50 and 0.60 across follow-up periods.ConclusionsCombined HGI and GG assessment may provide guidance on risk stratification and identification of high-risk individuals.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Comparing the Survival Analysis of Two or More Groups


